SNF 4435C

Drug Profile

SNF 4435C

Latest Information Update: 27 Nov 2007

Price : $50

At a glance

  • Originator Snow Brand Milk Products
  • Class Nitro compounds; Pyrones
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Immunological disorders

Most Recent Events

  • 08 Nov 2001 A study has been added to the Immunogical Disorders pharmacodynamics section
  • 05 Oct 1998 Preclinical development for Immunological disorders in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top